QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 发表日期：2016     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Pharmacokinetics and Disposition of Circulating Iridoids and Organic Acids in Rats Intravenously Receiving ReDuNing Injection 期刊论文 DRUG METABOLISM AND DISPOSITION, 2016, 卷号: 44, 期号: 11, 页码: 1853-1858 作者:  Cheng, Chen;  Du, Feifei;  Yu, Ke;  Xu, Fang;  Wang, Fengqing 收藏  |  浏览/下载：35/0  |  提交时间：2019/01/08 Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors 期刊论文 JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 卷号: 9 作者:  Sun, Yongkun;  Niu, Wei;  Du, Feng;  Du, Chunxia;  Li, Shuting 收藏  |  浏览/下载：41/0  |  提交时间：2019/01/08 Anlotinib  Anti-angiogenesis  Phase I study  Advanced refractory solid tumors  Pharmacokinetics  Safety   Supporting effect and application of bolt-net-anchor coupling support under extremely weak cementation formation 期刊论文 Caikuang yu Anquan Gongcheng Xuebao/Journal of Mining and Safety Engineering, 2016, 卷号: 33, 期号: 5, 页码: 770-778 作者:  Meng, Qingbin;  Han, Lijun;  Qiao, Weiguo;  Zhang, Jian;  Mei, Fengqing 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/16 Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors 期刊论文 2016, 卷号: 9, 期号: 1, 页码: 105 作者:  Sun, Yongkun;  Niu, Wei;  Du, Feng;  Du, Chunxia;  Li, Shuting 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04 Anlotinib  Anti-angiogenesis  Phase I study  Advanced refractory solid tumors  Pharmacokinetics  Safety